Literature DB >> 27117421

Accuracy of bioimpedance vector analysis and brain natriuretic peptide in detection of peripheral edema in acute and chronic heart failure.

Francesco Massari1, Massimo Iacoviello2, Pietro Scicchitano3, Filippo Mastropasqua4, Pietro Guida5, Graziano Riccioni6, Giuseppe Speziale7, Pasquale Caldarola8, Marco Matteo Ciccone2, Salvatore Di Somma9.   

Abstract

OBJECTIVE: To evaluate the role of bioelectrical impedance vector analysis (BIVA) and brain natriuretic peptide (BNP) in detecting peripheral congestion in heart failure (HF).
BACKGROUND: BIVA/BNP are biomarkers for congestion in acute (ADHF) and chronic HF.
METHODS: 487 ADHF and 413 chronic HF patients underwent BIVA and BNP tests.
RESULTS: BIVA was more accurate than BNP in detecting peripheral congestion both in ADHF (AUC 0.88 vs 0.57 respectively; p < 0.001) and chronic HF patients (AUC 0.89 vs 0.68, respectively; p < 0.001). In ADHF patients, the optimal BNP cut-off for discriminating presence or absence of edema was >870 pg/mL (PPV = 48% and NPV = 58%) whereas in chronic HF it was >216 pg/mL (PPV = 18% and NPV = 95%). The BIVA detected edema when the vector fell into the lower pole of 75th percentile tolerance ellipse (PPV = 84% and NPV = 78%) in ADHF, the lower pole of 50% (PPV = 68% and NPV = 95%) in chronic HF.
CONCLUSIONS: In HF patients, BIVA is an easy, fast technique to assess peripheral congestion, and is even more accurate than BNP.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute heart failure; BIVA; BNP; Chronic heart failure; Peripheral congestion

Mesh:

Substances:

Year:  2016        PMID: 27117421     DOI: 10.1016/j.hrtlng.2016.03.008

Source DB:  PubMed          Journal:  Heart Lung        ISSN: 0147-9563            Impact factor:   2.210


  6 in total

1.  Supraventricular tachycardia, pregnancy, and water: A new insight in lifesaving treatment of rhythm disorders.

Authors:  Francesco Massari; Pietro Scicchitano; Angela Potenza; Marco Sassara; Mariella Sanasi; Mariarosa Liccese; Marco Matteo Ciccone; Pasquale Caldarola
Journal:  Ann Noninvasive Electrocardiol       Date:  2018-04-10       Impact factor: 1.468

2.  The cost of inpatient management of heart failure patients: a microcosting study in the Irish healthcare setting.

Authors:  R B Morgan; L McCullagh; M Barry; C Daly
Journal:  Ir J Med Sci       Date:  2016-11-19       Impact factor: 1.568

Review 3.  Brain Natriuretic Peptide Biomarkers in Current Clinical and Therapeutic Scenarios of Heart Failure.

Authors:  Gianmarco Alcidi; Giovanni Goffredo; Michele Correale; Natale Daniele Brunetti; Massimo Iacoviello
Journal:  J Clin Med       Date:  2022-06-02       Impact factor: 4.964

4.  Body composition analysis in patients with acute heart failure: the Scale Heart Failure trial.

Authors:  Fiorangelo De Ieso; Markus Reinhold Mutke; Noe Karl Brasier; Christina Janitha Raichle; Bettina Keller; Celine Sucker; Khaled Abdelhamid; Tiziano Bloch; Pamela Reissenberger; Ladina Schönenberg; Sandro Kevin Fischer; Jonas Saboz; Nora Weber; Sabine Schädelin; Nicole Bruni; Patrick R Wright; Jens Eckstein
Journal:  ESC Heart Fail       Date:  2021-10-13

Review 5.  Should we overcome the resistance to bioelectrical impedance in heart failure?

Authors:  Stephen J Hankinson; Charles H Williams; Van-Khue Ton; Stephen S Gottlieb; Charles C Hong
Journal:  Expert Rev Med Devices       Date:  2020-07-13       Impact factor: 3.166

6.  Sex Differences in the Evaluation of Congestion Markers in Patients with Acute Heart Failure.

Authors:  Pietro Scicchitano; Claudio Paolillo; Micaela De Palo; Angela Potenza; Silvia Abruzzese; Marco Basile; Antonia Cannito; Maria Tangorra; Piero Guida; Pasquale Caldarola; Marco Matteo Ciccone; Francesco Massari
Journal:  J Cardiovasc Dev Dis       Date:  2022-02-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.